Biosimilars Around the World -
Last month’s Supreme Court ruling in Sandoz v. Amgen brought greater certainty to both biosimilar applicants and originators in the United States. The July 2017 issue of Sterne Kessler’s Global Patent Prosecution Newsletter includes information on worldwide biosimilar approvals and their global uptake, with a focus on the US, Europe, and Japan.
Please see full publication below for more information.